We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 492 results
  1. Amphetamine-induced prolonged disturbances in tissue levels of dopamine and serotonin in the rat brain

    Background

    A hallmark of psychostimulants is the persistence of neurobiological changes they produce. The difficulty in reversing long-time effects of...

    Ewa Taracha, Magdalena Czarna, ... Piotr Maciejak in Pharmacological Reports
    Article Open access 21 March 2023
  2. Investigation of the Membranotropic Properties of Acylated Peptide Derivatives of Dopamine and Serotonin Using the Pampa Method

    Peptide derivatives of dopamine (DA) and serotonin (5-hydroxytryptamine, 5-HT) acylated with lauric acid (LA) and oleic acid (OA), including...

    V. P. Shevchenko, L. A. Andreeva, ... N. F. Myasoedov in Pharmaceutical Chemistry Journal
    Article 17 August 2022
  3. A re-consideration of neural/receptor mechanisms in chemotherapy-induced nausea and vomiting: current scenario and future perspective

    The neural mechanisms and the receptors behind the course of chemotherapy-induced nausea and vomiting (CINV) are well described and considered...

    Ihsan Ullah, Muhammad Ayaz in Pharmacological Reports
    Article 16 August 2023
  4. Approach the prevention of chemotherapy-induced nausea and vomiting in older patients with care

    Chemotherapy-induced nausea and vomiting (CINV) negatively affects adherence to treatment and quality of life in older patients, and should be...

    Article 05 November 2022
  5. 1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia

    Background

    The aim of the present study was to evaluate the effect of 1MeTIQ on fear memory and social interaction in an MK-801-induced model of...

    Magdalena Białoń, Agnieszka Chocyk, ... Agnieszka Wąsik in Pharmacological Reports
    Article Open access 06 January 2021
  6. Effects of chronic delta-opioid receptor agonist on the excitability of hippocampal glutamate and brainstem monoamine neurons, anxiety, locomotion, and habituation in rats

    Background

    Short-term treatment with non-peptide agonists of delta-opioid receptors, such as agonist SNC80, induced behavioral effects in rodents,...

    Eliyahu Dremencov, Daniil Grinchii, ... Daniela Jezova in Pharmacological Reports
    Article 15 April 2023
  7. Uncovering the unique characteristics of different groups of 5-HT5AR ligands with reference to their interaction with the target protein

    Background

    The serotonin 5-HT 5A receptor has attracted much more research attention, due to the therapeutic potential of its ligands being...

    Szymon K. Kordylewski, Ryszard Bugno, ... Sabina Podlewska in Pharmacological Reports
    Article Open access 06 July 2024
  8. Antidepressant-like effect of dehydrozingerone from Zingiber officinale by elevating monoamines in brain: in silico and in vivo studies

    Background

    Dehydrozingerone (DHZ) is an active ingredient of Zingiber officinale and structural half analogue of curcumin. In the present study, DHZ...

    Sudheer Moorkoth, N. Sai Prathyusha, ... Nitesh Kumar in Pharmacological Reports
    Article Open access 28 June 2021
  9. Network analysis of monoamines involved in anxiety-like behavior in a rat model of osteoarthritis

    Background

    Chronic pain is a major health problem that affects a significant number of patients, resulting in personal suffering and substantial...

    Jakub Mlost, Magdalena Białoń, ... Katarzyna Starowicz in Pharmacological Reports
    Article Open access 05 January 2024
  10. Identification of genes regulated by trait sensitivity to negative feedback and prolonged alcohol consumption in rats

    Background

    The results of our previous studies demonstrated that low sensitivity to negative feedback (NF) is associated with increased vulnerability...

    Agata Cieslik-Starkiewicz, Karolina Noworyta, ... Rafal Rygula in Pharmacological Reports
    Article Open access 03 January 2024
  11. Modulating role of serotonergic signaling in sleep and memory

    Serotonin is an important neurotransmitter with various receptors and wide-range effects on physiological processes and cognitive functions including...

    Salar Vaseghi, Shirin Arjmandi-Rad, ... Mohammad-Reza Zarrindast in Pharmacological Reports
    Article 06 November 2021
  12. Psychedelics action and schizophrenia

    Psychedelics are compounds acting by serotonin 5-hydroxytryptamine (5-HT) 2A receptor activation and induce several behavioral responses. They are of...

    Marzena Maćkowiak in Pharmacological Reports
    Article Open access 30 October 2023
  13. Polypharmacology: promises and new drugs in 2022

    Polypharmacology is an emerging strategy of design, synthesis, and clinical implementation of pharmaceutical agents that act on multiple targets...

    Piotr Ryszkiewicz, Barbara Malinowska, Eberhard Schlicker in Pharmacological Reports
    Article Open access 06 June 2023
  14. Diagnose and treat constipation- or diarrhoea-predominant irritable bowel syndrome with confidence

    Irritable bowel syndrome (IBS) is diagnosed based on clinical criteria of regular abdominal pain and disordered defaecation. If first-line treatments...

    Caroline Fenton, Connie Kang in Drugs & Therapy Perspectives
    Article 14 March 2022
  15. Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission

    Background

    4-Iodo-2,5-dimethoxy- N -(2-methoxybenzyl)phenethylamine (25I-NBOMe) is a potent serotonin (5-HT) receptor agonist with hallucinogenic...

    Monika Herian, Adam Wojtas, ... Krystyna Gołembiowska in Pharmacological Reports
    Article Open access 10 November 2020
  16. The effect of valproate on the amino acids, monoamines, and kynurenic acid concentrations in brain structures involved in epileptogenesis in the pentylenetetrazol-kindled rats

    Background

    The study aimed to assess the influence of a single valproate (VPA) administration on inhibitory and excitatory neurotransmitter...

    Aleksandra Wisłowska-Stanek, Danuta Turzyńska, ... Piotr Maciejak in Pharmacological Reports
    Article 22 March 2024
  17. Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease

    Huntington’s disease (HD) is a paradigm of a genetic neurodegenerative disorder characterized by the expansion of CAG repeats in the HTT gene. This...

    Alaa Shafie, Amal Adnan Ashour, ... Md. Imtaiyaz Hassan in Archives of Pharmacal Research
    Article 19 May 2024
  18. Cordia dichotoma Fruits Aqueous Extracts Alleviates Depressive-Like Behavior in a Rat Model via Regulating Serotonergic Neurotransmitters

    Depression is a common mental illness caused by the interaction of social, psychological, and physical factors. The number of people suffering from...

    Zulifeiya Wusiman, Haliya Tuerxunmaimaiti, ... Maiwulanijiang Yizibula in Revista Brasileira de Farmacognosia
    Article 11 November 2023
  19. Estrogen fluctuations during the menopausal transition are a risk factor for depressive disorders

    Women are significantly more likely to develop depression than men. Fluctuations in the ovarian estrogen hormone levels are closely linked with...

    Justyna Turek, Łukasz Gąsior in Pharmacological Reports
    Article Open access 14 January 2023
  20. Exploring the Active Components of Ziziphus jujuba Mill. in Treatment of Depression by Network Pharmacology Combined with Neuroprotective Effects in SH-SY5Y Cells

    Depression is a common mental health disease, with the characteristics of significant and persistent low mood. Traditionally, Ziziphus jujuba Mill . ...

    Danqi Li, Weihong Li, ... Pinyi Gao in Pharmaceutical Chemistry Journal
    Article 01 August 2023
Did you find what you were looking for? Share feedback.